医保基金滥用治理
Search documents
医保卡不可变身购物卡
Jing Ji Ri Bao· 2025-12-01 22:25
医保卡被滥用源于多方面原因。部分地区在医疗器械备案和医保目录准入环节审核不严,致使一些缺乏 医疗价值的"伪医疗用品"得以进入结算渠道。同时,医保监管技术手段尚不完善,难以及时识别异常支 付、异常商品"挂码"等行为。此外,部分个人账户资金长期沉淀、使用效率不高的问题,也为违规消费 提供了可乘之机。为破解这一问题,相关改革正在稳步推进,个人账户的家庭共济范围不断扩大,跨省 共济"医保钱包"已在多个地区落地实施,旨在进一步提高资金使用效率、增强医疗保障功能。 近期,有媒体调查发现,一些药店和生产企业把牙刷、护肤品、洗脸巾等日用品包装成"一类、二类医 疗器械",再通过医保个人账户结算。网络上流传的"医保卡薅羊毛攻略"等内容,也诱导参保人将医疗 资金用于非医疗消费。尽管有关部门早已发布过预警提示,但医保卡变"购物卡"的乱象仍未得到根治。 医保基金是"救命钱",无论是统筹基金还是个人账户,都必须依法用于与医疗相关的支出。《中华人民 共和国社会保险法》明确规定,医保基金只能支付医疗费用,不能用于日常用品消费。医保卡变身"购 物卡",看似让消费者得了便宜,实际却打开了医保基金被套取的缺口,导致医保体系被侵蚀,最终损 害全体参 ...
根治医保卡变购物卡需打好组合拳
Bei Jing Qing Nian Bao· 2025-11-11 07:31
Core Viewpoint - The misuse of medical insurance cards as shopping cards is undermining the integrity of China's healthcare system, with companies disguising everyday products as medical devices to exploit insurance funds [1][2][4] Group 1: Current Situation - Various regions have reported ongoing fraudulent activities where non-medical products like toothbrushes and face masks are being processed through medical insurance accounts [1][2] - The practice of misusing medical insurance funds is a blatant violation of regulations, which stipulate that these funds should only be used for medical-related expenses [2][4] Group 2: Regulatory Challenges - The current regulatory framework is insufficient, allowing companies to circumvent laws by reclassifying everyday items as medical devices [2][3] - The lack of effective technical oversight in the medical insurance system has enabled these fraudulent practices to persist [3] Group 3: Proposed Solutions - To combat the misuse of medical insurance cards, a multi-faceted approach is necessary, including tightening regulations on medical device approvals and creating a negative list for borderline products [3] - Implementing big data technologies to monitor transaction patterns and establish an intelligent warning system is crucial for early detection of anomalies [3] - Strengthening social cooperation through regular inspections, reward systems for whistleblowers, and promoting self-regulation within the retail pharmacy industry can enhance compliance [3]